OpenVSafe by OpenVAERS
Search V-safe

JDA-11323-75075

2 vaccinations 3 coded responses 21 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
26-30
ZIP prefix
530 / WI
Registered
2022-02-18
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2022-02-16
    Dose 1 — Pfizer-BioNTech
  2. 2022-02-18
    Registered in v-safe
  3. 2022-02-18
    Health check-in — days 1–6 daily, dose 1
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  4. 2022-02-19
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches
    Adult check-in
  5. 2022-02-20
    Health check-in — days 1–6 daily, dose 1
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  6. 2022-02-21
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  7. 2022-02-22
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Headache, Fatigue or tiredness
    Adult check-in
  8. 2022-02-23
    Health check-in — day 7, dose 1
    Feeling: Good · Headache
    Adult check-in
  9. 2022-03-02
    Survey response — day 14, dose 1
    MedDRA: Headache — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Headaches on and off
    MedDRA releases: 2024-11 · check-in free text available
  10. 2022-03-09
    Dose 2 — Pfizer-BioNTech
  11. 2022-03-09
    Health check-in — day 0, dose 2
    Feeling: Fair · Site: Pain · Headache
    Adult check-in
  12. 2022-03-10
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities
    Adult check-in
  13. 2022-03-11
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  14. 2022-03-12
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  15. 2022-03-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  16. 2022-03-16
    Health check-in — day 7, dose 2
    Feeling: Good · Headache
    Adult check-in
  17. 2022-03-23
    Health check-in — day 14, dose 2
    Feeling: Fair
    Adult check-in
  18. 2022-03-31
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  19. 2022-04-06
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  20. 2022-04-15
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  21. 2022-04-20
    Health check-in — day 42, dose 2
    Feeling: Fair
    Adult check-in
  22. 2022-06-08
    Survey response — 3 months, dose 2
    MedDRA: Headache, Nasopharyngitis, Pyrexia — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Fever, headache, cold symptoms.
    MedDRA releases: 2024-11 · check-in free text available
  23. 2022-09-07
    Health check-in — 6 months, dose 2
    Feeling: Fair
    Adult check-in
  24. 2023-03-09
    Survey response — 12 months, dose 2
    MedDRA: Abortion spontaneous — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    MedDRA releases: 2024-11
  25. 2023-03-09
    Report sent to call center — 12 months, dose 2
    Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  26. 2023-03-10

Vaccinations

DoseDateManufacturerCo-administered
12022-02-16Pfizer-BioNTech No
22022-03-09Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2023-03-09 Unsuccessful

Free text

Release 11 — day 14, dose 1

2022-03-02

Symptoms: Headaches on and off

Release 11 — 3 months, dose 2

2022-06-08

Symptoms: Fever, headache, cold symptoms.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbortion spontaneous · · ✓
SDHeadache · · ✓
SDNasopharyngitis · · ✓
SDPyrexia · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release